All In Biotech

Drug Trial Radar · NCT06926491

Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia(AOBA Study)

A Multicenter, Open-label, Single-arm, Phase 3 Study of KK8398 (Infigratinib) in Patients With Achondroplasia (AOBA Study)

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

13

Actual

Start

Dec 1, 2024

Primary completion

May 31, 2029

Study completion May 31, 2031

Sponsor

Lead sponsor
Kyowa Kirin Co., Ltd.Industry
Sponsor type
Industry
First posted
Apr 13, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 3 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial will evaluate the efficacy of KK8398 on annualized height velocity after 52 weeks of repeated administration of KK8398 to patients with achondroplasia

Conditions

  • Achondroplasia

Interventions

  • KK8398Drug

    KK8398 will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in annualized height velocityTime frame: Pre-dose, Week 52

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Niigata University Medical and Dental Hospital

    Niigata, Japan

  • Okayama University Hospital

    Okayama, Japan

  • ISEIKAI International General Hospital

    Osaka, Japan

  • Osaka City General Hospital

    Osaka, Japan

  • Aichi Children's Health and Medical Center

    Ōbu, Aichi-ken, Japan

  • Osaka University Hospital

    Suita, Osaka, Japan

  • Osaka Women's and Children's Hospital

    Waizumi, Osaka, Japan

  • Tokyo Metropolitan Children's Medical Center

    Fuchū, Tokyo, Japan

  • Tottori University Hospital

    Yonago, Tottori, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.